metastatic/advanced OC (mOC) - 1st line (L1) | |
mOC - L1 - PDL1 positive | |
anti-PD-(L)1 | |
atezolizumab based treatment | |
atezolizumab plus SoC | IMagyn-050 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -